Dermafence has developed a proprietary technology for the treatment of burns. The company's technology is based on a GRAS formulation with a novel mechanism of action designed to bar energy from progressing to the deeper layers of the skin.
Dermafence has developed a first aid burn formulation that restores and protects epidermal "skin barrier" function following exposure to insults that introduce energy to the skin.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Materials & Substances
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals